Crossmark

The effects of Songling Xuemaikang capsule on vascular remodeling of stage 1 hypertension: a multicenter, randomized placebo-controlled trial protocol

Crossref DOI link: https://doi.org/10.1186/s12906-025-05038-y

Published Online: 2025-08-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Qiyu

Yu, Linghua

Zhang, Zenan

Zhuang, Zhixun

Tian, Wende

Wang, Anlu

Xu, Hao
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82230125)
License Information

Text and Data Mining valid from 2025-08-06

Version of Record valid from 2025-08-06
More Information

Article History

Received: 31 July 2024

Accepted: 14 July 2025

First Online: 6 August 2025

Declarations

:

: This study has been approved by the central IEC of Xiyuan Hospital of China Academy of Chinese Medical Sciences (Approval No. 2023.09.14v3.0). Participants will be asked to sign an informed consent(s) before participating in this study.

: Not applicable. No data are presented in this article.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below